CAS RN: 114681-65-1

GRGDNP

Product Availability

Choose a grade to view its available package options.

7 package records7 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260124 1ml In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260616 100mg In stock Shanghai Inquiry
Batchno.20250218 10mg In stock Shanghai Inquiry
Batchno.20260615 1mg In stock Shanghai Inquiry
Batchno.20260320 25mg In stock Shanghai Inquiry
Batchno.20260502 50mg In stock Shanghai Inquiry
Batchno.20251116 5mg In stock Shanghai Inquiry
  • Product code: starshine_CAS114681-65-1
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

114681-65-1 / (2S)-1-[(2S)-4-amino-2-[[(2S)-2-[[2-[[(2S)-2-[(2-aminoacetyl)amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-4-oxobutanoyl]pyrrolidine-2-carboxylic acid

RGD peptide (GRGDNP) | H-Gly-Arg-Gly-Asp-Asn-Pro-OH | GRGDNP

Standard CAS: 114681-65-1 Multi CAS: Yes

Basic Information

CAS
114681-65-1
Multi CAS
Yes
Molecular Formula
C23H38N10O10
Molecular Weight
614.600000
Exact Mass
614.277237
SMILES
C1C[C@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)C(=O)O
InChI
InChI=1S/C23H38N10O10/c24-9-16(35)30-11(3-1-5-28-23(26)27)19(39)29-10-17(36)31-12(8-18(37)38)20(40)32-13(7-15(25)34)21(41)33-6-2-4-14(33)22(42)43/h11-14H,1-10,24H2,(H2,25,34)(H,29,39)(H,30,35)(H,31,36)(H,32,40)(H,37,38)(H,42,43)(H4,26,27,28)/t11-,12-,13-,14-/m0/s1
InChIKey
CWAHAVYVGPRZJU-XUXIUFHCSA-N
Synonyms
RGD peptide (GRGDNP) H-Gly-Arg-Gly-Asp-Asn-Pro-OH GRGDNP GLY-ARG-GLY-ASP-ASN-PRO MFCD00153556

Computed Properties

Structural Parameters

Heavy atom count
43
Fraction Csp3
0.61
Rotatable bonds
18
H-bond acceptors
10
H-bond donors
10
Molar refractivity
146.2
TPSA
344.82

LogP / Solubility

WLOGP
-6.01
MLOGP
-5.23
XLogP3
-8.4
Consensus LogP
-6.55
Log S (ESOL)
1.32
Class (ESOL)
Highly soluble
Log S (Ali)
-0.26
Class (Ali)
Very soluble
Log S (SILICOS-IT)
-0.83
Class (SILICOS-IT)
Very soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-10.73

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
6

Get In Touch

Contact Us